JohnLesterGoudreauDO

Neurology • East Lansing, MI

Associate Professor, Neurology/Ophthalmology, Michigan State University, College of Human Medicine

Join to view full profile

Dr. Goudreau is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Goudreau's full profile

Already have an account?

Office
804 Service Rd # A217
East Lansing, MI 48824
Phone+1 517-353-8122

Fax+1 517-432-3713

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 1997 - 2000
Michigan State University College of Osteopathic MedicineClass of 1995

Certifications & Licensure

MI State License 2001 - 2026
MN State License 1997 - 2005
FL State License 1999 - 2002
AZ State License 1996 - 1997
American Board of Psychiatry and Neurology Neurology
AOA Board of Neurology and Psychiatry Neurology

Clinical Trials

A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation Start of enrollment: 2013 Sep 01
Terminated
Phase 2
Efficacy of Isradipine in Early Parkinson Disease Start of enrollment: 2014 Nov 01
Completed
Phase 3

Publications & Presentations

PubMed

83 citations
Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial.
Tanya Simuni, Brian K. Fiske, Kalpana Merchant, Christopher S. Coffey, Elizabeth A. Klingner
JAMA Neurology. 2021-03-01
90 citations
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial
Michael A. Schwarzschild, Alberto Ascherio, Cindy Casaceli, Gary C. Curhan, Rebecca Fitzgerald
JAMA. 2021-09-14
860 citations
A call for transparent reporting to optimize the predictive value of preclinical research
Story C. Landis, Susan G. Amara, Khusru Asadullah, Christopher P. Austin, Robi Blumenstein
Nature. 2012-10-11

Grant Support

The Role Of Parkin In Selective Dopamine Neuronal DegenerationNational Institute Of Neurological Disorders And Stroke2010–2012
Michigan State University Parkinson Disease Clinical CenterNational Institute Of Neurological Disorders And Stroke2006–2011
Neuroprotective Factors In Hypothalamic Dopamine NeuronsNational Institute Of Neurological Disorders And Stroke2005–2006
Apocynin Neuroprotection In A Parkinson'S Disease ModelNational Institute Of Neurological Disorders And Stroke2005–2006

Professional Memberships